Emerald Plants Health Source (OCTQB:STNN)  (“EPHS” or the “Company”) and Pure Global Cannabis Inc. (TSXV:PURE and OTC: PRCNF (“Pure”) are pleased to announce the companies have entered into a memorandum of understanding (“MOU”) through which the parties shall seek to enter into a wholesale supply agreement (“Supply Agreement”) whereby Pure will purchase 1,000 kg of dried flower from EPHS. The total quantity will be shipped periodically throughout a 12-month period commencing on or about July 2019, as product becomes available.

EPHS’s downtown Montreal facility prides itself on its capabilities to cultivate premium, craft grown cannabis at a market leading costs per gram.  Lower cost of cultivation combined with ultra premium outputs places EPHS in an advantageous position within the cannabis landscape, for both the medical and adult-use markets.  With over 350,000 square feet of cultivation canopy slated for their second site in Merritt, B.C, the smaller Montreal site will continue to be used as a craft growlab and a site to perfect automated environments for the larger Merritt play.


“We are thrilled to be supplying Pure with our signature ‘Craft Grown with Care’ cannabis, cultivated at our downtown Montreal facility.  The firming of this relationship is a testament to our unique cultivation process, and the team behind it,” says Steven Perry, President of EPHS. “The team at Pure aligns with our mission and vision of providing both the medical and adult-use markets with the best possible quality of dried flower.”

This agreement follows EPHS achieving their cultivation license in late October 2018. EPHS has since been focused on acquiring unique genetics, enhancing their proprietary cultivation environment and the acquisition of land for the larger facility in Merritt, B.C.

“Pure Global is continuously looking for ways to get the highest quality products for distribution to our clinics, patients, and our online customers,” says Malay Panchal, President and CEO of Pure Global. “The production method and superior product from EPHS ensures that we can deliver on our corporate promise.”

ABOUT PURE GLOBAL CANNABIS
Pure Global Cannabis Inc. (TSX.V:PURE;OTC: PRCNF; FRA:1QS) is an innovation-based cannabis company led by experienced pharma, biotechnology, horticultural, and consumer packaged goods (CPG) experts. The Company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Cannabis Act. The Company’s Brampton campus houses facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. Pure Global will produce branded and white-labeled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, and recreational legal markets with uniquely formulated and purified concentrates. The Company is using the Canadian market as a springboard to develop and manufacture GMP-compliant cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.

ABOUT EPHS
EPHS Holdings Inc. (OCTQB: STNN) is a Montreal based wellness-focused company and licensed producer of connoisseur-quality craft grown cannabis, pursuant to the Cannabis Regulations under the Cannabis Act (Canada).  With over 25 years of combined cannabis cultivation and power management experience, the team at EPHS will provide the Canadian and global cannabis markets with connoisseur-quality craft grown cannabis at the lowest possible cost.  EPHS is committed to fostering B2B relationships along with purchasing, licensing, and/or developing authentic brands to support its craft quality cultivation outputs.

FORWARD LOOKING STATEMENTS
Certain statements contained in this news release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations, estimations, and projections at the time the statements are made, and involve risks and uncertainties which could cause actual results or events to differ materially from those currently anticipated, including, but not limited to, delays, difficulties, changed strategies, or unanticipated factors or circumstances affecting EPHS Holdings Inc. and its business. Any forward-looking statement speaks only as of the date on which the statement is made, and, except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for the Company to predict all such factors. When considering these forward-looking statements, one should be mindful of the risk factors and other cautionary statements found in the Company’s filings with the SEC, including, but not limited to, its Form 10, its subsequent Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. The risk factors and other factors noted in the Company’s SEC filings could cause actual results to differ materially from those contained in any forward-looking statement.

About Emerald Plants Health Source
www.ephsholdings.com

Source: www.newswire.ca

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less